Evolva Holding SA : Ingredients - Company Profile, SWOT and Financial Analysis
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Canadeans "Evolva Holding SA : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers and acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Evolva Holding SA"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Synopsis
Evolva Holding SA (Evolva) is a biotechnology company based in Switzerland. The company primarily focuses on discovery and development of ingredients for the consumer healthcare, nutrition and pharmaceutical market. Its product pipeline includes resveratrol, a natural compound derived from grapes with anti-aging benefits; components of vanilla, stevia and saffron; Pomecins, the companys proprietary compound used primarily for food and crop protection and Valencene, an orange flavour and fragrance ingredient used in food and beverage, personal care and household products. The company is also into clinical research and development of EV-077 and EV-035 for the treatment of diabetic complications and bacterial infection respectively. Additionally, Evolva involves in several projects and proprietary programs in the areas of consumer healthcare, nutrition and pharma. The company has collaboration agreements with a number of global companies including Cargill, BASF, Roquette and International Flavors and Fragrances. Evolva has operations in the US, the UK, Switzerland, Denmark and India. The company is headquartered in Reinach, Switzerland.
- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.
- The SWOT analysis identifies the companys strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.
- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.
Reasons To Buy
- Quickly enhance your understanding of "Evolva Holding SA"
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors businesses better.
- Recognize potential partnerships and suppliers.
Key Highlights
Evolva Holding SA (Evolva) is a biotechnology company based in Switzerland. The company primarily focuses on discovery and development of ingredients for the consumer healthcare, nutrition and pharmaceutical market. Its product pipeline includes resveratrol, a natural compound derived from grapes with anti-aging benefits; components of vanilla, stevia and saffron; Pomecins, the companys proprietary compound used primarily for food and crop protection and Valencene, an orange flavour and fragrance ingredient used in food and beverage, personal care and household products. The company is also into clinical research and development of EV-077 and EV-035 for the treatment of diabetic complications and bacterial infection respectively. Additionally, Evolva involves in several projects and proprietary programs in the areas of consumer healthcare, nutrition and pharma. The company has collaboration agreements with a number of global companies including Cargill, BASF, Roquette and International Flavors and Fragrances. Evolva has operations in the US, the UK, Switzerland, Denmark and India. The company is headquartered in Reinach, Switzerland.
Canadeans "Evolva Holding SA : Ingredients - Company Profile, SWOT and Financial Analysis" contains in depth information and data about the company and its operations. The profile contains a company overview, key facts, major products and services, SWOT analysis, business description, company history, financial analysis, mergers and acquisitions, recent developments, key employees, company locations and subsidiaries as well as competitive benchmarking data.
Key Findings
This report is a crucial resource for industry executives and anyone looking to access key information about "Evolva Holding SA"
The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. Canadean strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Synopsis
Evolva Holding SA (Evolva) is a biotechnology company based in Switzerland. The company primarily focuses on discovery and development of ingredients for the consumer healthcare, nutrition and pharmaceutical market. Its product pipeline includes resveratrol, a natural compound derived from grapes with anti-aging benefits; components of vanilla, stevia and saffron; Pomecins, the companys proprietary compound used primarily for food and crop protection and Valencene, an orange flavour and fragrance ingredient used in food and beverage, personal care and household products. The company is also into clinical research and development of EV-077 and EV-035 for the treatment of diabetic complications and bacterial infection respectively. Additionally, Evolva involves in several projects and proprietary programs in the areas of consumer healthcare, nutrition and pharma. The company has collaboration agreements with a number of global companies including Cargill, BASF, Roquette and International Flavors and Fragrances. Evolva has operations in the US, the UK, Switzerland, Denmark and India. The company is headquartered in Reinach, Switzerland.
- This business intelligence report presents the key company information, essential to understanding industry challenges and competitors.
- The SWOT analysis identifies the companys strengths, weaknesses, opportunities for growth and threats. The key competitors are dissected alongside the larger challenges that the industry is facing.
- The company profile relays all current information about the business operations, including key employees, major products and services, company history, locations and subsidiaries alongside a supporting statement from the Chairman and Managing Director.
Reasons To Buy
- Quickly enhance your understanding of "Evolva Holding SA"
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry.
- Increase business/sales activities by understanding your competitors businesses better.
- Recognize potential partnerships and suppliers.
Key Highlights
Evolva Holding SA (Evolva) is a biotechnology company based in Switzerland. The company primarily focuses on discovery and development of ingredients for the consumer healthcare, nutrition and pharmaceutical market. Its product pipeline includes resveratrol, a natural compound derived from grapes with anti-aging benefits; components of vanilla, stevia and saffron; Pomecins, the companys proprietary compound used primarily for food and crop protection and Valencene, an orange flavour and fragrance ingredient used in food and beverage, personal care and household products. The company is also into clinical research and development of EV-077 and EV-035 for the treatment of diabetic complications and bacterial infection respectively. Additionally, Evolva involves in several projects and proprietary programs in the areas of consumer healthcare, nutrition and pharma. The company has collaboration agreements with a number of global companies including Cargill, BASF, Roquette and International Flavors and Fragrances. Evolva has operations in the US, the UK, Switzerland, Denmark and India. The company is headquartered in Reinach, Switzerland.
TABLE OF CONTENTS
1 Evolva Holding SA
2 Evolva Holding SA - Key Employees
3 Evolva Holding SA - Key Employees Biographies
4 Evolva Holding SA - Major Products and Services
5 Evolva Holding SA - History
6 Evolva Holding SA - Company Statement
7 Evolva Holding SA - Locations and Subsidiaries
7.1 Evolva Holding SA - Head Office
7.2 Evolva Holding SA - Other Locations and Subsidiaries
8 Evolva Holding SA - Business Analysis
8.1 Evolva Holding SA - Company Overview
8.2 Evolva Holding SA - Business Description
9 Evolva Holding SA - SWOT Analysis
9.1 Evolva Holding SA - SWOT Analysis - Overview
9.2 Evolva Holding SA - Strengths
9.2.1 Strength - Strategic Partnerships with Global Companies
9.2.2 Strength - Focus on Research and Development
9.2.3 Strength - Broad End Market
9.3 Evolva Holding SA - Weaknesses
9.3.1 Weakness - Dependence on Selected Customers
9.4 Evolva Holding SA - Opportunities
9.4.1 Opportunity - Rising Demand for Natural Sweeteners
9.4.2 Opportunity - Positive Outlook for the Global Pharmaceutical Industry
9.4.3 Opportunity - Strategic Initiatives
9.5 Evolva Holding SA - Threats
9.5.1 Threat - Shortage of Skilled Manpower in EU
9.5.2 Threat - Growing Demand for Alternative Sweeteners
9.5.3 Threat - Stringent Regulations
10 Evolva Holding SA - Company Financial Analysis
10.1 Evolva Holding SA - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
11 Evolva Holding SA - Interim ratios
11.1.1 Evolva Holding SA - Financial ratios: Capital Market Ratios
11.2 Evolva Holding SA - Financial Performance and Ratio Charts
11.2.1 Evolva Holding SA - Revenue and Operating margin
11.2.2 Evolva Holding SA - Asset and Liabilities
11.2.3 Evolva Holding SA - Operational Efficiency
11.2.4 Evolva Holding SA - Solvency
11.3 Evolva Holding SA - Competitive Benchmarking
11.3.1 Evolva Holding SA - Efficiency
11.3.2 Evolva Holding SA - Turnover: Inventory and Asset
11.3.3 Evolva Holding SA - Liquidity
12 Evolva Holding SA - Mergers and Acquisitions and Partnerships
12.1 Evolva Holding SA - MandA and Partnerships Strategy
13 Evolva Holding SA - Recent Developments
14 Appendix
14.1 Methodology
14.2 Evolva Holding SA - Ratio Definitions
14.3 Disclaimer
Table 2: Evolva Holding SA - Key Employees Biographies
Table 3: Evolva Holding SA - Major Products and Services
Table 4: Evolva Holding SA - History
Table 5: Evolva Holding SA - Subsidiaries
Table 6: Evolva Holding SA - Locations
Table 7: Evolva Holding SA - Annual ratios
Table 8: Evolva Holding SA - Interim ratios
Table 9: Evolva Holding SA - Capital Market Ratios
Figure 2: Evolva Holding SA - Asset and Liabilities
Figure 3: Evolva Holding SA - Operational Efficiency
Figure 4: Evolva Holding SA - Solvency
Figure 5: Evolva Holding SA - Efficiency
Figure 6: Evolva Holding SA - Turnover: Inventory and Asset
Figure 7: Evolva Holding SA - Liquidity
2 Evolva Holding SA - Key Employees
3 Evolva Holding SA - Key Employees Biographies
4 Evolva Holding SA - Major Products and Services
5 Evolva Holding SA - History
6 Evolva Holding SA - Company Statement
7 Evolva Holding SA - Locations and Subsidiaries
7.1 Evolva Holding SA - Head Office
7.2 Evolva Holding SA - Other Locations and Subsidiaries
8 Evolva Holding SA - Business Analysis
8.1 Evolva Holding SA - Company Overview
8.2 Evolva Holding SA - Business Description
9 Evolva Holding SA - SWOT Analysis
9.1 Evolva Holding SA - SWOT Analysis - Overview
9.2 Evolva Holding SA - Strengths
9.2.1 Strength - Strategic Partnerships with Global Companies
9.2.2 Strength - Focus on Research and Development
9.2.3 Strength - Broad End Market
9.3 Evolva Holding SA - Weaknesses
9.3.1 Weakness - Dependence on Selected Customers
9.4 Evolva Holding SA - Opportunities
9.4.1 Opportunity - Rising Demand for Natural Sweeteners
9.4.2 Opportunity - Positive Outlook for the Global Pharmaceutical Industry
9.4.3 Opportunity - Strategic Initiatives
9.5 Evolva Holding SA - Threats
9.5.1 Threat - Shortage of Skilled Manpower in EU
9.5.2 Threat - Growing Demand for Alternative Sweeteners
9.5.3 Threat - Stringent Regulations
10 Evolva Holding SA - Company Financial Analysis
10.1 Evolva Holding SA - Five Year Snapshot: Overview of Financial and Operational Performance Indicators
11 Evolva Holding SA - Interim ratios
11.1.1 Evolva Holding SA - Financial ratios: Capital Market Ratios
11.2 Evolva Holding SA - Financial Performance and Ratio Charts
11.2.1 Evolva Holding SA - Revenue and Operating margin
11.2.2 Evolva Holding SA - Asset and Liabilities
11.2.3 Evolva Holding SA - Operational Efficiency
11.2.4 Evolva Holding SA - Solvency
11.3 Evolva Holding SA - Competitive Benchmarking
11.3.1 Evolva Holding SA - Efficiency
11.3.2 Evolva Holding SA - Turnover: Inventory and Asset
11.3.3 Evolva Holding SA - Liquidity
12 Evolva Holding SA - Mergers and Acquisitions and Partnerships
12.1 Evolva Holding SA - MandA and Partnerships Strategy
13 Evolva Holding SA - Recent Developments
14 Appendix
14.1 Methodology
14.2 Evolva Holding SA - Ratio Definitions
14.3 Disclaimer
List Of Tables
Table 1: Evolva Holding SA - Key EmployeesTable 2: Evolva Holding SA - Key Employees Biographies
Table 3: Evolva Holding SA - Major Products and Services
Table 4: Evolva Holding SA - History
Table 5: Evolva Holding SA - Subsidiaries
Table 6: Evolva Holding SA - Locations
Table 7: Evolva Holding SA - Annual ratios
Table 8: Evolva Holding SA - Interim ratios
Table 9: Evolva Holding SA - Capital Market Ratios
List Of Figures
Figure 1: Evolva Holding SA - Revenue and Operating ProfitFigure 2: Evolva Holding SA - Asset and Liabilities
Figure 3: Evolva Holding SA - Operational Efficiency
Figure 4: Evolva Holding SA - Solvency
Figure 5: Evolva Holding SA - Efficiency
Figure 6: Evolva Holding SA - Turnover: Inventory and Asset
Figure 7: Evolva Holding SA - Liquidity
RELATED REPORTS
Azelis Holding SA - Strategy, SWOT and Corporate Finance Report
Azelis Holding SA - Strategy, SWOT and Corporate Finance ReportAzelis Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report
USD 175 View ReportMassilly Holding SA - Strategy, SWOT and Corporate Finance Report
Massilly Holding SA - Strategy, SWOT and Corporate Finance ReportMassilly Holding SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report
USD 175 View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS